Invitae (NVTA) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket
 


Invitae Corporation  (NYSE: NVTA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Invitae's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Invitae's ROA in the third quarter of 2023?
Invitae Corporation had a negative return on assets (ROA) of -106.92%, due to the net loss of $-1 billion, during the twelve months ending in the third quarter of 2023.

However, within the Healthcare sector 916 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2023 from 4486 to 4928.

What is ROA?



Return On Assets (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -75.25 % -33.3 % -65.3 % -63.45 % -61.26 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1,441 -800 -3,117 -3,106 -3,212
Return On Assets (TTM) -106.92 % -46.81 % -164.95 % -117.26 % -93.04 %
NVTA's Total Ranking # 4928 # 4486 # 5350 # 6007 # 5225
Total Assets (TTM) in million 475 1,451 1,615 1,849 1,919
Seq. Total Assets Change -67.26 % -10.15 % -12.7 % -3.61 % -11.78 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 40
Sector # 917
Overall # 4838

Return On Assets Statistics
High Average Low
-8.04 %
-57.8 %
-156.56 %
(Dec 31 2021)   (Mar 31 2023)





Financial Statements
Invitae's Assets $ 475 million NVTA's Balance sheet
Invitae's Income $ -942 million Quarterly NVTA's Income Statement
NVTA's Income by Division See NVTA's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change -61.48 % 41.69 % 333.49 % 176.22 % 34.05 %
Total Assets in million 1,849 4,801 3,388 782 283
Y / Y Net Income Change - - - - -
Net Income in million -3,106 -379 -602 -242 -129
Annual Return On Assets -167.96 % -7.89 % -17.77 % -30.96 % -45.72 %




More Return On Assets Ratios
NVTA's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NVTA's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NVTA's Competitors
Subscribers only: Roa for Invitae's Suppliers
Subscribers only: Return On Assets for NVTA's Customers

You may also want to know
NVTA's Roi NVTA's Inventory Turnover Ratio NVTA's Growth Rates NVTA's Dividend Comparisons
NVTA's Profitability Ratios NVTA's Asset Turnover Ratio NVTA's Dividend Growth
NVTA's Roe NVTA's Valuation Ratios NVTA's Financial Strength Ratios NVTA's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA


Date modified: 2026-09-26T07:13:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.